{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T13:34:23Z","timestamp":1769434463148,"version":"3.49.0"},"reference-count":30,"publisher":"Baishideng Publishing Group Inc.","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.3173","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T06:08:41Z","timestamp":1246601321000},"page":"3173","source":"Crossref","is-referenced-by-count":42,"title":["Translation and validation of the Nepean Dyspepsia Index for functional dyspepsia in China"],"prefix":"10.3748","volume":"15","author":[{"given":"Xiao-Ping","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan-Rong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Rong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Yuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Piessevaux H, De Winter B, Louis E, Muls V, De Looze D, Pelckmans P, Deltenre M, Urbain D, Tack J. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil 2009;21:378-388.","DOI":"10.1111\/j.1365-2982.2009.01262.x"},{"key":"ref2","unstructured":"Talley NJ, Silverstein MD, Agr&eacute;us L, Nyr&eacute;n O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998;114:582-595."},{"key":"ref3","unstructured":"Kang XQ, Liu ZW, Xie B, Niu XY, Xiao YY, He C. The incidence of Functional Dyspepsia of parts of citizens in Tianjin. Zhonghua Xiaohua Zazhi 2002;22:191-192."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther 2001;15:207-216.","DOI":"10.1046\/j.1365-2036.2001.00900.x"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Mon&eacute;s J, Adan A, Seg&uacute; JL, L&oacute;pez JS, Art&eacute;s M, Guerrero T. Quality of life in functional dyspepsia. Dig Dis Sci 2002;47:20-26.","DOI":"10.1023\/A:1013294815971"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004;19:643-654.","DOI":"10.1111\/j.1365-2036.2004.01897.x"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Holtmann G, Adam B, Haag S, Collet W, Gr&uuml;newald E, Windeck T. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther 2003;18:1099-1105.","DOI":"10.1046\/j.1365-2036.2003.01767.x"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Meineche-Schmidt V, Talley NJ, Pap A, Kordecki H, Schmid V, Ohlsson L, Wahlqvist P, Wiklund I, Bolling-Sternevald E. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study. Scand J Gastroenterol 1999;34:566-574.","DOI":"10.1080\/003655299750026010"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Rentz AM, Battista C, Trudeau E, Jones R, Robinson P, Sloan S, Mathur S, Frank L, Revicki DA. Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature. Pharmacoeconomics 2001;19:349-363.","DOI":"10.2165\/00019053-200119040-00003"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"M&ouml;nkem&uuml;ller K, Malfertheiner P. Drug treatment of functional dyspepsia. World J Gastroenterol 2006;12:2694-2700.","DOI":"10.3748\/wjg.v12.i17.2694"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Madisch A, Miehlke S, Labenz J. Management of functional dyspepsia: Unsolved problems and new perspectives. World J Gastroenterol 2005;11:6577-6581.","DOI":"10.3748\/wjg.v11.i42.6577"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, Holtmann G, Verlinden M, Jones M. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther 1999;13:225-235.","DOI":"10.1046\/j.1365-2036.1999.00445.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Hashash JG, Abdul-Baki H, Azar C, Elhajj II, El Zahabi L, Chaar HF, Sharara AI. Clinical trial: a randomized controlled cross-over study of flupenthixol + melitracen in functional dyspepsia. Aliment Pharmacol Ther 2008;27:1148-1155.","DOI":"10.1111\/j.1365-2036.2008.03677.x"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Talley NJ, Tack J, Ptak T, Gupta R, Gigu&egrave;re M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut 2008;57:740-746.","DOI":"10.1136\/gut.2007.132449"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol 2001;96:1422-1428.","DOI":"10.1111\/j.1572-0241.2001.03683.x"},{"key":"ref16","unstructured":"Cho YK, Choi MG, Kim SH, Lee IS, Kim SW, Chung IS, Lee SY, Choi SC, Seol SY. [The effect of mosapride on quality of life in functional dyspepsia]. Korean J Gastroenterol 2004;43:160-167."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol 1999;94:2390-2397.","DOI":"10.1111\/j.1572-0241.1999.01363.x"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Boeckxstaens GE, Hirsch DP, Kuiken SD, Heisterkamp SH, Tytgat GN. The proximal stomach and postprandial symptoms in functional dyspeptics. Am J Gastroenterol 2002;97:40-48.","DOI":"10.1111\/j.1572-0241.2002.05421.x"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006;354:832-840.","DOI":"10.1056\/NEJMoa052639"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.","DOI":"10.1053\/j.gastro.2006.03.008"},{"key":"ref21","unstructured":"Leplege A, Verdier A. The adaptation of health status measures: methodological aspects of the translation procedure. The international sssessment of health-related quality of life: theory, translation, measurement and analysis Rapid Communications: Oxford; 1995;93-101."},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993;2:441-449.","DOI":"10.1007\/BF00422218"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Halder SL, Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 2004;19:233-242.","DOI":"10.1111\/j.0269-2813.2004.01807.x"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Frankhuisen R, Van Herwaarden MA, Heijkoop R, Baron A, Vermeijden R, Smout AJ, Gooszen HG, Samsom M. Functional dyspepsia and irritable bowel syndrome in patients with achalasia and its association with non-cardiac chest pain and a decreased health-related quality of life. Scand J Gastroenterol 2009;44:687-691.","DOI":"10.1080\/00365520902783709"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 1999;6:l-55.","DOI":"10.1080\/10705519909540118"},{"key":"ref26","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483."},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Kupcinskas L, Lafolie P, Lignell A, Kiudelis G, Jonaitis L, Adamonis K, Andersen LP, Wadstr&ouml;m T. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study. Phytomedicine 2008;15:391-399.","DOI":"10.1016\/j.phymed.2008.04.004"},{"key":"ref28","unstructured":"Sararaks S, Azman AB, Low LL, Rugayah B, Aziah AM, Hooi LN, Abdul Razak M, Norhaya MR, Lim KB, Azian AA. Validity and reliability of the SF-36: the Malaysian context. Med J Malaysia 2005;60:163-179."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Duffett S, Braunholtz D, Mason S, Richards ID, Dowell AC, Axon AT. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther 1998;12:1257-1262.","DOI":"10.1046\/j.1365-2036.1998.00404.x"},{"key":"ref30","unstructured":"Browne MW, Cudeck R. Alternative ways of assessing model fit. Testing structural equation models Sage: Beverly Hills; 1993;136-162."}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i25\/3173.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T02:21:02Z","timestamp":1558405262000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i25\/3173.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":30,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.3173","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}